Studies Currently Recruiting Patients
Click on the title of trial for more information.

Allergy and Immunology:

• Pimecrolimus Cream 1% Plus Tropical Corticosteroid In Patients With Severe Atopic Dermatitis. (2-17 years of age)
  
  Contact:
  Michelle Rhea
  Phone: (804) 628-1562

• Efficacy and Safety of Omalizumab in Children (6-<12 Years) With Moderate-Severe, Inadequately Controlled Allergic Asthma.
  
  Contact:
  Juellisa Gadd
  Phone: (804) 628-0212

• A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma
  
  Contact:
  Juellisa Gadd
  Phone: (804) 628-0212
  
  
• Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics
  

Contact
Michelle Rhea
Phone: (804) 628-1562


• Study of Allergic Rhinitis in Patients Who Also Have Asthma
  

Contact
Michelle Rhea
Phone (804) 628-1562

Genetics/ Metabolism:

• Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
  
  Contact:
  Paige Holmes
  Phone: (804) 628-0212

• A Postmarketing Surveillance Program for Nutropin, Nutropin AQ, and Protropin
  
  Contact:
  Paige Holmes
  Phone: (804) 628-0212

• National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
  
  Contact:
  Paige Holmes
  Phone: (804) 628-0212
  

Hematology/Oncology:

• A Stratified Sickle Event Randomized Trial (ASSERT). 
  
  Contact:
  Neena Sikka
  Phone: (804) 628-1569
  or
  Erin Tatum
  Phone: (804) 628-0399
  
  
• Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children
  

Contact
Erin Tatum
Phone: (804) 628-0399

Pulmonary:

• Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients With P. Aeruginosa.
  
  Contact:
  Juellisa Gadd
  Phone: (804) 628-0212     

• Safety and Efficacy Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients With P. Aeruginosa.
  
  Contact:
  Juellisa Gadd
  Phone: (804) 628-0212     

• International Safety and Efficacy Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients.
  
  Contact:
  Juellisa Gadd
  Phone: (804) 628-0212     

Virginia Commonwealth University | VCU Health System | School of Medicine
Children's Pavilion
1001 East Marshall Street
P.O. Box 980264
Richmond, Virginia 23298-0264
Phone: (804) 828-7035 | Fax: (804) 828-8559
Email: scantor@vcu.edu
Updated: 01/17/2008